GOV.UK
Medicines, medical devices and blood regulation and safety
On this page
Services
-
Sunset clause: request for public health exemption
Apply for a public health exemption from the sunset clause.
-
Blood facility declaration form
Blood facility declaration form to be completed and returned to MHRA.
-
Blood establishment authorisation application form
Form to apply for a blood establishment authorisation and guidance on completing the form.
Guidance and regulation
- Zika virus: country specific risk
- NHS terms and conditions: procuring goods and services
- Managing common infections: guidance for primary care
- Supply unlicensed medicinal products (specials)
- Good manufacturing practice and good distribution practice
News and communications
- All T34 ambulatory syringe pumps – update concerning battery information (MDA/2018/035)
- Hydrochlorothiazide: risk of non-melanoma skin cancer, particularly in long-term use
- Systemic and inhaled fluoroquinolones: small increased risk of aortic aneurysm and dissection; advice for prescribing in high-risk patients
- Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction
Research and statistics
- Mefloquine (Lariam) prescribing in the UK armed forces: 12 September 2016 to 30 September 2018
- European Antibiotic Awareness Day: evaluations
- Medicines: licensing time-based performance measures
- Family Practitioner Services Statistics for Northern Ireland 2017/18
- Early access to medicines scheme applications: pending, refused, granted
Policy papers and consultations
- Statutory scheme to control costs of branded health service medicines
- Health institution exemption for IVDR/MDR
- Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)
- Innovation: Queen’s University Belfast
- Innovation: MHRA advises the Cell Therapy Catapult of regulatory requirements
Transparency and freedom of information releases
- PPRS aggregate net sales and payment information: August 2018
- Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2018 - 2019
- Clinical trials for medicines: authorisation assessment performance
- Medicines and Healthcare products Regulatory Agency spending over £25,000: 2018 to 2019
- Medicines and Healthcare products Regulatory Agency spending over £25,000: 2017 to 2018
Organisations
Explore these sub-topics
- Blood regulation and safety
- Clinical trials and investigations
- Conferences and events
- Good practice, inspections and enforcement
- Herbal and homeopathic medicines
- Manufacturing, wholesaling, importing and exporting medicines
- Marketing authorisations, variations and licensing guidance
- Medical devices regulation and safety
- Vigilance, safety alerts and guidance